FTC

All articles by FTC

PBMs under fire as FTC prepares legal action over insulin practices
PBMs under fire as FTC prepares legal action over insulin practices
Molly Huth
July 10, 2024
3:29 pm

Amid heightened scrutiny in Washington, D.C., a trade association representing community pharmacists launched an ad campaign targeting the industry’s so-called middlemen.

FTC attorney urges brands to assess risks of AI influencers on children
FTC attorney urges brands to assess risks of AI influencers on children
Jessica Heygate
July 3, 2024
11:00 am

At a recent online event, Michelle Rosenthal expressed concerns about companies ‘misleading’ children with AI characters that are hard to distinguish from real humans.

FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta
FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta
Marc Iskowitz
May 3, 2024
10:38 am

The FTC crackdown comes six months after the regulator challenged drugmakers in a similar fashion.

FTC chief says tech advancements risk healthcare price fixing
FTC chief says tech advancements risk healthcare price fixing
Julie Rovner and David Hilzenrath, KFF Health News
April 24, 2024
10:30 am

New technologies are making it easier for companies to fix prices and discriminate against individual consumers, the Biden administration’s top consumer watchdog said Tuesday.

The FTC is attacking drugmakers’ ‘patent thickets’
The FTC is attacking drugmakers’ ‘patent thickets’
Elisabeth Rosenthal, KFF Health News
January 31, 2024
3:00 pm

The Federal Trade Commission has challenged the validity of over 100 drug product patents in an effort to increase competition and potentially lower some prices.

IQVIA punts on Propel Media, DeepIntent acquisitions after FTC challenge
IQVIA punts on Propel Media, DeepIntent acquisitions after FTC challenge
Jack O'Brien
January 5, 2024
12:59 pm

The temporary block of the deal that was first announced at the tail end of 2022 was ultimately enough to sink IQVIA and DeepIntent’s plans, according to DeepIntent CEO Chris Paquette.

FTC chief gears up for a showdown with private equity
FTC chief gears up for a showdown with private equity
Harris Meyer, KFF Health News
November 30, 2023
3:00 pm

Over the past three years, FTC and Department of Justice officials have signaled they would apply more scrutiny to private equity acquisitions in health care.

FTC to crack down on ‘sham patents’ in FDA’s Orange Book
FTC to crack down on ‘sham patents’ in FDA’s Orange Book
Lecia Bushak
November 10, 2023
4:18 pm

The FTC has notified 10 pharma companies, including AbbVie and AstraZeneca, that they’ve improperly listed patents on certain drug products.

FTC allows Amgen’s $27.8B purchase of Horizon to proceed
FTC allows Amgen’s $27.8B purchase of Horizon to proceed
Jack O'Brien
September 1, 2023
9:32 am

The greenlight from the FTC marks a sudden turn in the Amgen-Horizon merger, one of the most pivotal business developments the industry had seen this year.

A taste of what’s to come?
A taste of what’s to come?
Lecia Bushak
August 8, 2023
1:54 pm

In the absence of broader federal privacy regulation, the Federal Trade Commission has cracked down on healthcare companies using data for marketing purposes.

  • From Our Partners